New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, including Vyepti, Lundbeck’s drug for the prophylaxis of migraine.
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, including Vyepti, Lundbeck’s drug for the prophylaxis of migraine.